BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11864710)

  • 1. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect.
    Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Balbo A; Trovati M
    Thromb Res; 2002 Jan; 105(1):71-8. PubMed ID: 11864710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.
    Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Trovati M
    Eur J Clin Invest; 2001 May; 31(5):452-61. PubMed ID: 11380598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect.
    Trovati M; Massucco P; Mattiello L; Mularoni E; Cavalot F; Anfossi G
    Diabetes; 1994 Aug; 43(8):1015-9. PubMed ID: 7518780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
    Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
    Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate.
    Trovati M; Anfossi G; Massucco P; Mattiello L; Costamagna C; Piretto V; Mularoni E; Cavalot F; Bosia A; Ghigo D
    Diabetes; 1997 May; 46(5):742-9. PubMed ID: 9133539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide.
    Trovati M; Massucco P; Mattiello L; Piretto V; Cavalot F; Mularoni E; Anfossi G
    Diabetes; 1996 Jun; 45(6):768-70. PubMed ID: 8635651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations.
    Anfossi G; Massucco P; Mattiello L; Piretto V; Mularoni E; Cavalot F; Paoletti G; Trovati M
    Thromb Res; 1996 Apr; 82(1):57-68. PubMed ID: 8731510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
    Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
    Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity.
    Anfossi G; Russo I; Massucco P; Mattiello L; Doronzo G; De Salve A; Trovati M
    Eur J Clin Invest; 2004 Jul; 34(7):482-9. PubMed ID: 15255785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
    Banerjee D; Mazumder S; Sinha AK
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):585-91. PubMed ID: 25083729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism.
    Massucco P; Mattiello L; Russo I; Traversa M; Doronzo G; Anfossi G; Trovati M
    Thromb Haemost; 2005 Mar; 93(3):517-26. PubMed ID: 15735804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of human platelet function by L-canavanine: differential effects of low and high concentrations.
    Anfossi G; Massucco P; Mattiello L; Cavalot F; Perna P; Giori A; Tassone F; Trovati M
    Gen Pharmacol; 1999 Mar; 32(3):321-8. PubMed ID: 10211586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between milrinone and adenosine in the inhibition of human platelet response.
    Anfossi G; Massucco P; Piretto V; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Gen Pharmacol; 1996 Oct; 27(7):1149-54. PubMed ID: 8981060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS; Belushkina NN; Grigoryev NB
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.